Innovative Treatment and Mechanisms

Innovative Treatment and Mechanisms

Making the difference for people with complex brain disorders
Making the difference for people with complex brain disorders
We are committed to advance outcomes for patients with psychosis and other complex brain disorders through innovative treatments and understanding underlying mechanisms. We have brought key accomplishments in understanding hallucinations, using language as a marker for psychosis, applying nutritional interventions to psychiatry and neurology, tapering antipsychotic medication and optimizing the treatment for women with psychosis. 
The group has a proven track record in securing multimillion-euro grants, leading national and international consortia, communication with lay audience and publishing in high-impact journals. Our work is strongly interdisciplinary across multiple foci. We strong coalitions with partners in the field of linguistics, molecular imaging, microbiology, pharmacology, AI and gynecology, which enables us apply top-notch techniques and know-how to the field of neuropsychiatry.
Average BPND PET-images of SSD, SIB, and HC
Group mean of [11C]UCB-J Non-displaceable Binding Potential (BPND) PET-images in Schizophrenia Spectrum Disorder (SSD), their healthy siblings (SIB), and healthy controls (HC). The figure displays the average BPND PET-images of SSD (N - 24) (lower panel), SIB (N - 25) (middle panel), and HC (N = 26) (upper panel).

Contact

Bote Smid
Research Coordinator, Staff

Center for Clinical Neuroscience and Cognition
University Medical Center Groningen
Triade building, entrance 24, room KZ1.06
Groningen, Netherlands